Tripos has promoted Dieter Schmidt-Base to senior vice president of worldwide sales from vice president of European sales, while Elizabeth Holbrook, formerly vice president of sales in North America and Pacific Rim, has left the company, Tripos said. In his new role, Schmidt-Base will oversee the restructuring of Tripos’ sales organization to create a stronger focus on product and service sales, the company said. Schmidt-Base will be responsible for creating a new group of business development specialists focused on enterprise informatics service contracts and drug discovery research contracts. Before joining Tripos, Schmidt-Base worked as a research associate at the University of Wisconsin in Madison on organo-lead compounds for protein structure determination.
Richard Gill has joined Signet Laboratories as president and CEO, succeeding founder Ronald Casciato, who will assume the role of executive chairman. Gill was most recently the president and CEO of AnVil, which ceased operations in June 2003.
Herbert Fritsche has been tapped as the chairman of Health Discovery’s scientific advisory board. Fritsche is a professor of laboratory medicine and chief of the clinical chemistry section at the University of Texas, MD Anderson Cancer Center in Houston, Texas.